Rationale and Public Health Implications of Changing CHD Risk Factor Definitions
- 1 April 2007
- journal article
- review article
- Published by Annual Reviews in Annual Review of Public Health
- Vol. 28 (1), 321-344
- https://doi.org/10.1146/annurev.publhealth.28.021406.144141
Abstract
The definition of disease is central to the practice of medicine and to public health policy. Practice guidelines set standards for disease identification and treatment. Quality care is often defined as adherence to these guidelines. Over the past few years, the diagnostic thresholds for several common medical conditions have been lowered, resulting in a substantial expansion in the market for health care. The most recent guidelines for high blood pressure, high cholesterol, and impaired fasting glucose each define a high percentage of the adult population as in need of regular medical attention. Under the latest proposed thresholds, virtually the entire adult population qualifies for a chronic condition diagnosis. We evaluate the health and financial outcomes associated with changes in diagnostic thresholds for the prevention of three risk factors for cardiovascular disease and stroke: blood pressure, serum cholesterol, and fasting plasma glucose. Estimates of the numbers of people affected, the cost implications, and the overall public health consequences are offered.Keywords
This publication has 85 references indexed in Scilit:
- Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Circulation, 2005
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)BMJ, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)The American Journal of Cardiology, 2001
- Primary Prevention of Ischemic StrokeStroke, 2001
- Hypertension in the Very Elderly Trial (HYVET)Drugs & Aging, 2001
- Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)The American Journal of Cardiology, 1997
- Prevalence of Hypertension in the US Adult PopulationHypertension, 1995
- Labeling of Hypertensive PatientsNew England Journal of Medicine, 1983
- Increased Absenteeism from Work after Detection and Labeling of Hypertensive PatientsNew England Journal of Medicine, 1978